Atria Wealth Solutions Inc. Reduces Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Atria Wealth Solutions Inc. trimmed its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 10.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 17,381 shares of the financial services provider’s stock after selling 2,079 shares during the period. Atria Wealth Solutions Inc.’s holdings in iShares Biotechnology ETF were worth $2,298,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Darwin Wealth Management LLC purchased a new stake in iShares Biotechnology ETF during the third quarter worth $29,000. Highline Wealth Partners LLC purchased a new stake in iShares Biotechnology ETF during the 3rd quarter valued at about $30,000. HHM Wealth Advisors LLC increased its holdings in iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after buying an additional 150 shares during the period. Newbridge Financial Services Group Inc. acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter worth $33,000. Finally, Hager Investment Management Services LLC purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at about $34,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 0.4 %

iShares Biotechnology ETF stock opened at $138.91 on Friday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The business’s 50-day moving average price is $135.61 and its 200 day moving average price is $140.77.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.